MustGrow Biologics Corp.
MGROF
$0.6588
-$0.0576-8.04%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 50.12% | 254.17% | |||
| Gross Profit | 431.53% | -254.17% | |||
| SG&A Expenses | 170.95% | -3.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 133.55% | -17.19% | |||
| Operating Income | -99.52% | 17.19% | |||
| Income Before Tax | -75.63% | 8.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -75.63% | 8.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -75.63% | 8.55% | |||
| EBIT | -99.52% | 17.19% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -75.74% | 8.72% | |||
| Normalized Basic EPS | -75.29% | 8.60% | |||
| EPS Diluted | -75.74% | 8.72% | |||
| Normalized Diluted EPS | -75.29% | 8.60% | |||
| Average Basic Shares Outstanding | 0.00% | 0.34% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
